Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.03 (-3.33%)
Close on Nov 13, 2026Market cap $14.51MP/E –Yield –
Marker Therapeutics cash
Cash and short-term investments held at the end of each period.
Marker Therapeutics's cash was $11.33M at Jun 30, 2026. For fiscal 2025 it was $16.07M, down 16.3% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $61.75M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.07M | -16.3% |
| FY2024 | Dec 31, 2024 | $19.19M | +27.0% |
| FY2023 | Dec 31, 2023 | $15.11M | +28.3% |
| FY2022 | Dec 31, 2022 | $11.78M | -72.9% |
| FY2021 | Dec 31, 2021 | $43.50M | +103.7% |
| FY2020 | Dec 31, 2020 | $21.35M | -51.4% |
| FY2019 | Dec 31, 2019 | $43.90M | -28.9% |
| FY2018 | Dec 31, 2018 | $61.75M | +1103.8% |
| FY2017 | Dec 31, 2017 | $5.13M | -34.7% |
| FY2016 | Dec 31, 2016 | $7.85M | +19.4% |
| FY2015 | Dec 31, 2015 | $6.58M | +4533.2% |
| FY2014 | Dec 31, 2014 | $141.94K | +192.1% |
| FY2013 | Dec 31, 2013 | $48.59K | +43.6% |
| FY2012 | Dec 31, 2012 | $33.84K | -86.5% |
| FY2011 | Dec 31, 2011 | $250.23K | +964.1% |
| FY2010 | Dec 31, 2010 | $23.52K | -83.4% |
| FY2009 | Dec 31, 2009 | $141.43K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.33M | -4.1% |
| Q1 FY2026 | Mar 31, 2026 | $14.92M | +8.9% |
| Q4 FY2025 | Dec 31, 2025 | $16.07M | -16.3% |
| Q3 FY2025 | Sep 30, 2025 | $17.59M | +95.5% |
| Q2 FY2025 | Jun 30, 2025 | $11.81M | +51.5% |
| Q1 FY2025 | Mar 31, 2025 | $13.69M | +20.9% |
| Q4 FY2024 | Dec 31, 2024 | $19.19M | +27.0% |
| Q3 FY2024 | Sep 30, 2024 | $9.00M | -48.5% |
| Q2 FY2024 | Jun 30, 2024 | $7.80M | -57.0% |
| Q1 FY2024 | Mar 31, 2024 | $11.32M | +76.9% |
| Q4 FY2023 | Dec 31, 2023 | $15.11M | +28.3% |
| Q3 FY2023 | Sep 30, 2023 | $17.47M | -3.3% |
| Q2 FY2023 | Jun 30, 2023 | $18.12M | -29.8% |
| Q1 FY2023 | Mar 31, 2023 | $6.40M | -77.8% |
| Q4 FY2022 | Dec 31, 2022 | $11.78M | -72.9% |
| Q3 FY2022 | Sep 30, 2022 | $18.08M | -62.9% |
| Q2 FY2022 | Jun 30, 2022 | $25.82M | -54.9% |
| Q1 FY2022 | Mar 31, 2022 | $28.82M | -55.3% |
| Q4 FY2021 | Dec 31, 2021 | $43.50M | +103.7% |
| Q3 FY2021 | Sep 30, 2021 | $48.71M | +80.7% |
| Q2 FY2021 | Jun 30, 2021 | $57.22M | +78.1% |
| Q1 FY2021 | Mar 31, 2021 | $64.51M | +60.2% |
| Q4 FY2020 | Dec 31, 2020 | $21.35M | -51.4% |
| Q3 FY2020 | Sep 30, 2020 | $26.96M | -44.4% |
| Q2 FY2020 | Jun 30, 2020 | $32.12M | -39.9% |
| Q1 FY2020 | Mar 31, 2020 | $40.26M | -30.2% |
| Q4 FY2019 | Dec 31, 2019 | $43.90M | -28.9% |
| Q3 FY2019 | Sep 30, 2019 | $48.48M | +522.9% |
| Q2 FY2019 | Jun 30, 2019 | $53.44M | +1808.0% |
| Q1 FY2019 | Mar 31, 2019 | $57.71M | +1025.0% |
| Q4 FY2018 | Dec 31, 2018 | $61.75M | +711.6% |
| Q2 FY2018 | Jun 30, 2018 | $7.78M | -21.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.80M | -52.7% |
| Q4 FY2017 | Dec 31, 2017 | $5.13M | -34.7% |
| Q3 FY2017 | Sep 30, 2017 | $7.61M | -20.6% |
| Q2 FY2017 | Jun 30, 2017 | $9.96M | +164.4% |
| Q1 FY2017 | Mar 31, 2017 | $5.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $9.59M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.77M | – |
See a number that looks wrong?